http://wiki.jackslab.org/index.php?action=history&feed=atom&title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E
犬内脏血管肉瘤中的肿瘤相关巨噬细胞 - 版本历史
2026-09-11T05:17:34Z
本wiki的该页面的版本历史
MediaWiki 1.19.2
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16832&oldid=prev
Comcat：/* References */
2024-06-28T04:07:36Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 04:07的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第128行：</td>
<td colspan="2" class="diff-lineno">第128行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [57]  [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (MTP-PE) adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] 临床癌症研究 1995 <del class="diffchange diffchange-inline">    米伐木肽（Mifamurtide），又称为利米洛肽（Liposomal muramyl tripeptide phosphatidylethanolamine，LMTP-PE），是一种用于治疗非转移性骨肉瘤（non-metastatic osteosarcoma）的药物。它是一款肽类药物，通过激活人体免疫系统，增强免疫细胞对恶性肿瘤的攻击能力，从而提高治疗效果。米伐木肽 (mifamurtide) 的参考价：规格为 4mg，价格为 15480 元一盒</del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [57]  [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (MTP-PE) adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] 临床癌症研究 1995  </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16831&oldid=prev
Comcat：/* References */
2024-06-28T04:05:37Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 04:05的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第128行：</td>
<td colspan="2" class="diff-lineno">第128行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (MTP-PE) adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995<del class="diffchange diffchange-inline">] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]</del>] 临床癌症研究 1995    米伐木肽（Mifamurtide），又称为利米洛肽（Liposomal muramyl tripeptide phosphatidylethanolamine，LMTP-PE），是一种用于治疗非转移性骨肉瘤（non-metastatic osteosarcoma）的药物。它是一款肽类药物，通过激活人体免疫系统，增强免疫细胞对恶性肿瘤的攻击能力，从而提高治疗效果。米伐木肽 (mifamurtide) 的参考价：规格为 4mg，价格为 15480 元一盒</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [57<ins class="diffchange diffchange-inline">]  [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]</ins>] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (MTP-PE) adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] 临床癌症研究 1995    米伐木肽（Mifamurtide），又称为利米洛肽（Liposomal muramyl tripeptide phosphatidylethanolamine，LMTP-PE），是一种用于治疗非转移性骨肉瘤（non-metastatic osteosarcoma）的药物。它是一款肽类药物，通过激活人体免疫系统，增强免疫细胞对恶性肿瘤的攻击能力，从而提高治疗效果。米伐木肽 (mifamurtide) 的参考价：规格为 4mg，价格为 15480 元一盒</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16830&oldid=prev
Comcat：/* References */
2024-06-28T04:05:02Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 04:05的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第128行：</td>
<td colspan="2" class="diff-lineno">第128行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (MTP-PE) adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] 临床癌症研究 1995</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (MTP-PE) adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] 临床癌症研究 1995 <ins class="diffchange diffchange-inline">    米伐木肽（Mifamurtide），又称为利米洛肽（Liposomal muramyl tripeptide phosphatidylethanolamine，LMTP-PE），是一种用于治疗非转移性骨肉瘤（non-metastatic osteosarcoma）的药物。它是一款肽类药物，通过激活人体免疫系统，增强免疫细胞对恶性肿瘤的攻击能力，从而提高治疗效果。米伐木肽 (mifamurtide) 的参考价：规格为 4mg，价格为 15480 元一盒</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16828&oldid=prev
Comcat：/* References */
2024-06-28T04:00:58Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 04:00的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第128行：</td>
<td colspan="2" class="diff-lineno">第128行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] 临床癌症研究 1995</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine <ins class="diffchange diffchange-inline">(MTP-PE) </ins>adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] 临床癌症研究 1995</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16827&oldid=prev
Comcat：/* References */
2024-06-28T03:59:26Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 03:59的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第129行：</td>
<td colspan="2" class="diff-lineno">第129行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] 临床癌症研究 1995</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] 临床癌症研究 1995</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[<del class="diffchange diffchange-inline">Muramyl二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂</del>]]</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[<ins class="diffchange diffchange-inline">胞壁酰二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂</ins>]]</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[<del class="diffchange diffchange-inline">通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞</del>]]</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[<ins class="diffchange diffchange-inline">通过静脉注射含有胞壁酰二肽的脂质体根除自发性转移和激活肺泡巨噬细胞</ins>]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16826&oldid=prev
Comcat：/* References */
2024-06-28T02:27:02Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 02:27的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第128行：</td>
<td colspan="2" class="diff-lineno">第128行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] 临床癌症研究 1995</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[Muramyl二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[Muramyl二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del class="diffchange diffchange-inline">* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] 临床癌症研究 1995</del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> </div></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del class="diffchange diffchange-inline">    </del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [[狗狗心包积液]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [[狗狗心包积液]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br></div></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16825&oldid=prev
Comcat：/* References */
2024-06-28T02:26:31Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 02:26的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第131行：</td>
<td colspan="2" class="diff-lineno">第131行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[<del class="diffchange diffchange-inline">脂质体封装的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验</del>]] 临床癌症研究 1995</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[<ins class="diffchange diffchange-inline">脂质体包封的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验</ins>]] 临床癌症研究 1995</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">    </ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [[狗狗心包积液]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [[狗狗心包积液]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br></div></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16824&oldid=prev
Comcat：/* References */
2024-06-28T02:25:19Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 02:25的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第131行：</td>
<td colspan="2" class="diff-lineno">第131行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体封装的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]]<del class="diffchange diffchange-inline">。临床癌症研究 </del>1995</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] [[脂质体封装的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]] <ins class="diffchange diffchange-inline">临床癌症研究 </ins>1995</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [[狗狗心包积液]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [[狗狗心包积液]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br></div></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16823&oldid=prev
Comcat：/* References */
2024-06-28T02:25:12Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 02:25的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第131行：</td>
<td colspan="2" class="diff-lineno">第131行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] <del class="diffchange diffchange-inline">脂质体封装的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验。临床癌症研究 </del>1995</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] <ins class="diffchange diffchange-inline">[[脂质体封装的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验]]。临床癌症研究 </ins>1995</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [[狗狗心包积液]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [[狗狗心包积液]]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br></div></td></tr>
</table>
Comcat
http://wiki.jackslab.org/index.php?title=%E7%8A%AC%E5%86%85%E8%84%8F%E8%A1%80%E7%AE%A1%E8%82%89%E7%98%A4%E4%B8%AD%E7%9A%84%E8%82%BF%E7%98%A4%E7%9B%B8%E5%85%B3%E5%B7%A8%E5%99%AC%E7%BB%86%E8%83%9E&diff=16821&oldid=prev
Comcat：/* References */
2024-06-28T02:23:51Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">←上一版本</td>
<td colspan='2' style="background-color: white; color:black;">2024年6月28日 (五) 02:23的版本</td>
</tr><tr><td colspan="2" class="diff-lineno">第128行：</td>
<td colspan="2" class="diff-lineno">第128行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== References ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del style="color: red; font-weight: bold; text-decoration: none;">* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</del></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[Muramyl二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [42] [https://pubmed.ncbi.nlm.nih.gov/22180736/ Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011] [[Muramyl二肽及其衍生物：免疫疾病和癌症治疗中的肽佐剂]]</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">* [13] [https://pubmed.ncbi.nlm.nih.gov/6940181/ Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci U S A. 1981] [[通过静脉注射含有胞壁基二肽的脂质体根除自发性转移和激活肺泡巨噬细胞]]</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] 脂质体封装的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验。临床癌症研究 1995</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* [57] [https://pubmed.ncbi.nlm.nih.gov/9815908/ Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res. 1995] 脂质体封装的胞壁酰三肽磷脂酰乙醇胺辅助免疫治疗狗脾血管肉瘤：一项随机多机构临床试验。临床癌症研究 1995</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
</table>
Comcat